Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access for Third Quarter Earnings Conference Call Tuesday, October 29, 2002 Live At 4:30 P.M. Eastern Time
Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access for Third Quarter Earnings Conference Call Tuesday, October 29, 2002 Live At 4:30 P.M. Eastern Time SAN DIEGO, Sep 30, 2002 (BUSINESS WIRE) -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), announced today that it will host both a
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Drug Discovery Collaboration With Ferring Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Announces Drug Discovery Collaboration With Ferring Pharmaceuticals, Inc. SAN DIEGO, May 28, 2002 /PRNewswire-FirstCall via COMTEX/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) ("Arena") today announced the signing of a research and license agreement with Ferring
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access for First Quarter Earnings Conference Call Wednesday, April 24, 2002 Live at 4:30 p.m. Eastern Time
Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access for First Quarter Earnings Conference Call Wednesday, April 24, 2002 Live at 4:30 p.m. Eastern Time SAN DIEGO, Apr 4, 2002 /PRNewswire-FirstCall via COMTEX/ -- Arena Pharmaceuticals, Inc.
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Completes an Initial Human Tissue Mapping of G Protein-Coupled Receptors
Arena Pharmaceuticals, Inc. Completes an Initial Human Tissue Mapping of G Protein-Coupled Receptors SAN DIEGO, Nov. 7 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that it has completed its initial analysis of human G protein-coupled receptor (GPCR) gene expression in
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access to Review 2001 Guidance During a Wednesday September 5, 2001 Conference Call, Live at 4:15 P.M. Eastern Time
Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access to Review 2001 Guidance During a Wednesday September 5, 2001 Conference Call, Live at 4:15 P.M. Eastern Time SAN DIEGO, Aug 31, 2001 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that it will host both
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Multi-Receptor CART Collaboration With TaiGen Biotechnology Co., Ltd.
Arena Pharmaceuticals, Inc. Announces Multi-Receptor CART Collaboration With TaiGen Biotechnology Co., Ltd. SAN DIEGO, Aug 20, 2001 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA); ("Arena") today announced the signing of a license agreement with TaiGen Biotechnology Co., Ltd.
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Olfactory Receptor Agreement With ICI
Arena Pharmaceuticals, Inc. Announces Olfactory Receptor Agreement With ICI SAN DIEGO, July 9 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that it has entered into an agreement with the ICI group to apply Arena's proprietary CART technology to olfactory and gustatory G
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access For Second Quarter Earnings Conference Call Monday July 23, 2001 Live At 4:30 P.M. Eastern Time
Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access For Second Quarter Earnings Conference Call Monday July 23, 2001 Live At 4:30 P.M. Eastern Time SAN DIEGO, Jul 5, 2001 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that it will host both a telephone
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option
Arena Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option SAN DIEGO, Jul 2, 2001 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the underwriting group managed by Thomas Weisel Partners LLC, Dain Rauscher Wessels, ABN AMRO Rothschild LLC and Lazard
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Follow-on Offering Of 5,000,000 Shares of Common Stock
Arena Pharmaceuticals, Inc. Announces Follow-on Offering Of 5,000,000 Shares of Common Stock SAN DIEGO, June 22 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that its follow-on offering of 5,000,000 shares of its common stock was priced on June 21, 2001 at $27.50 per
View HTML